Zentalis Pharmaceuticals, Inc. Common Stock

ZNTLNASDAQUSD
5.00 USD
0.05 (1.01%)AT CLOSE (11:59 AM EDT)
4.80
0.20 (4.00%)
POST MARKET (AS OF 07:34 PM EDT)
Post Market
AS OF 07:34 PM EDT
4.80
0.20 (4.00%)
🔴Market: CLOSED

Zentalis Pharmaceuticals, Inc. Common Stock (ZNTL) is currently trading at $4.99. ZNTL shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Aug 6, 2026.

Open?$4.92
High?$5.15
Low?$4.92
Prev. Close?$4.95
Volume?701.8K
Avg. Volume?1.4M
VWAP?$5.02
Rel. Volume?0.49x
Bid / Ask
Bid?$4.79 × 4.6K
Ask?$5.25 × 500
Spread?$0.46
Midpoint?$5.02
Valuation & Ratios
Market Cap?352.4M
Shares Out?71.2M
Float?47.1M
Float %?66.1%
P/E Ratio?N/A
P/B Ratio?1.93
EPS?-$1.74
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
Employees
106
Market Cap
352.4M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2020-04-03
Address
10275 SCIENCE CENTER DRIVE
SAN DIEGO, CA 92121
Phone: (858) 263-4333
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+3/3)
Medium-Term (Wave)? Bullish(+3/3)
Short-Term (Ripple)? Bullish(+3/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
34
Piotroski F-Score?0/9Weak
Altman Z-Score?-4.81Distress
Confidence?56%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?13.06%High
Short Interest?6.1M
Days to Cover?6.3
Free Float47.1M
Avg Daily Volume971.5K
Settlement Date2026-07-15
Financial Health
Current Ratio?6.19Strong
Quick Ratio?6.19Strong
Cash Ratio?0.91Adequate
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A
P/B?
Peers
100
S&P
76
1.93CHEAP
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
S&P
97
-2.2CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
S&P
3
-68.0%WEAK
ROA?
S&P
3
-49.1%WEAK
Cash Flow & Enterprise
FCF?$-125601000
Enterprise Value?$320.4M
Fundamentals ratios updated end of day